Skip to main content
Erschienen in: Uro-News 6/2023

07.06.2023 | Andrologie | Zertifizierte Fortbildung

Testosteronmangel - eine interdisziplinäre Herausforderung

Eine Betrachtung über den "urologischen Tellerrand" hinaus

verfasst von: Prof. Dr. med. Frank Sommer, Prof. Dr. Tibor Szarvas, Dr. Magnus Baumhäkel, Dr. med. Tobias Jäger

Erschienen in: Uro-News | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Auszug

Nicht nur erektile Dysfunktion und Libidoverlust können auf einen Testosteronmangel hinweisen, sondern auch unspezifische Symptome wie Antriebslosigkeit, Schlafstörungen oder Stimmungsschwankungen. So vielfältig wie die Anzeichen sind auch die möglichen Ursachen eines symptomatischen Testosteronmangels und damit einhergehende Begleiterkrankungen. Das macht ihn zu einer besonderen diagnostischen und therapeutischen Herausforderung, die interdisziplinär betrachtet werden muss. …
Literatur
1.
Zurück zum Zitat Zitzmann M et al. The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men. Aging Male 2022;25:134-44 Zitzmann M et al. The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men. Aging Male 2022;25:134-44
2.
Zurück zum Zitat Dohle GR et al. EAU Guidelines on Male Hypogonadism. European Association of Urology 2019; https://go.sn.pub/3547dH (letzter Aufruf: 12.4.2023) Dohle GR et al. EAU Guidelines on Male Hypogonadism. European Association of Urology 2019; https://​go.​sn.​pub/​3547dH (letzter Aufruf: 12.4.2023)
3.
Zurück zum Zitat Salonia A et al. EAU Guidelines on Sexual and Reproductive Health. European Association of Urology 2022; https://go.sn.pub/dYETX5 (letzter Aufruf: 12.4.2023) Salonia A et al. EAU Guidelines on Sexual and Reproductive Health. European Association of Urology 2022; https://​go.​sn.​pub/​dYETX5 (letzter Aufruf: 12.4.2023)
4.
Zurück zum Zitat Kelsey TW et al. A Validated Age-Related Normative Model for Male Total Testosterone Shows Increasing Variance but No Decline after Age 40 Years. PLoS One 2014;9:e109346 Kelsey TW et al. A Validated Age-Related Normative Model for Male Total Testosterone Shows Increasing Variance but No Decline after Age 40 Years. PLoS One 2014;9:e109346
5.
Zurück zum Zitat Mulligan T et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762-9 Mulligan T et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762-9
6.
Zurück zum Zitat Basaria S et al. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain 2015;156:280-8 Basaria S et al. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain 2015;156:280-8
7.
Zurück zum Zitat Rosen RC et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004;20:607-17 Rosen RC et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004;20:607-17
8.
Zurück zum Zitat Cunningham GR et al. Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab 2016;101:3096-104 Cunningham GR et al. Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab 2016;101:3096-104
9.
Zurück zum Zitat Kouidrat Y et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 2017;34:1185-92 Kouidrat Y et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 2017;34:1185-92
10.
Zurück zum Zitat Bebb R et al. Sexual Dysfunction and Hypogonadism in Men With Diabetes. Can J Diabetes 2018;42:S228-33 Bebb R et al. Sexual Dysfunction and Hypogonadism in Men With Diabetes. Can J Diabetes 2018;42:S228-33
11.
Zurück zum Zitat Zitzmann M. Die T4DM-Studie. J Urol Urogynäkol AT 2021;28:56-7 Zitzmann M. Die T4DM-Studie. J Urol Urogynäkol AT 2021;28:56-7
12.
Zurück zum Zitat Gravas S et al. Management of Non-neurogenic Male LUTS. European Association of Urology 2023; https://go.sn.pub/W8Bjit (letzter Aufruf: 12.4.2023) Gravas S et al. Management of Non-neurogenic Male LUTS. European Association of Urology 2023; https://​go.​sn.​pub/​W8Bjit (letzter Aufruf: 12.4.2023)
13.
Zurück zum Zitat Vartolomei L et al. Lower urinary tract symptoms are associated with clinically relevant depression, anxiety, and stress symptoms. Aging Male 2022;25:62-6 Vartolomei L et al. Lower urinary tract symptoms are associated with clinically relevant depression, anxiety, and stress symptoms. Aging Male 2022;25:62-6
14.
Zurück zum Zitat Zitzmann M et al. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-43 Zitzmann M et al. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-43
15.
Zurück zum Zitat Shores MM et al. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004;61:162-7 Shores MM et al. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004;61:162-7
16.
Zurück zum Zitat Schneider G et al. Depressive Symptoms in Men Aged 50 Years and Older and Their Relationship to Genetic Androgen Receptor Polymorphism and Sex Hormone Levels in Three Different Samples. J Geriatr Psychiatry 2011;19:274-83 Schneider G et al. Depressive Symptoms in Men Aged 50 Years and Older and Their Relationship to Genetic Androgen Receptor Polymorphism and Sex Hormone Levels in Three Different Samples. J Geriatr Psychiatry 2011;19:274-83
17.
Zurück zum Zitat Pope HG et al. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:105-11 Pope HG et al. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:105-11
18.
Zurück zum Zitat Wang C et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-98 Wang C et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-98
19.
Zurück zum Zitat Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103:1715-44 Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103:1715-44
20.
Zurück zum Zitat Ory J et al. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. J Urol 2022;207:1295-301 Ory J et al. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. J Urol 2022;207:1295-301
21.
Zurück zum Zitat Saad F et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011;165:675-85 Saad F et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011;165:675-85
Metadaten
Titel
Testosteronmangel - eine interdisziplinäre Herausforderung
Eine Betrachtung über den "urologischen Tellerrand" hinaus
verfasst von
Prof. Dr. med. Frank Sommer
Prof. Dr. Tibor Szarvas
Dr. Magnus Baumhäkel
Dr. med. Tobias Jäger
Publikationsdatum
07.06.2023

Weitere Artikel der Ausgabe 6/2023

Uro-News 6/2023 Zur Ausgabe

Industrieforum

Industrieforum

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.